CyCann Pharmaceuticals is planning to be the first Cypriot medicinal cannabis producer, our goal is to be the largest Cypriot producer of effective European Union Good Manufacturing Practice (EU-GMP) certified medicinal cannabis, to the global markets.
About CyCann Pharmaceuticals
Located in the Limassol District of Cyprus, CyCann Pharmaceuticals will become a strategic medicinal cannabis supplier to the European market, with operations including a state-of-the-art glass cultivation and extraction/processing facility. CyCann Pharmaceuticals have a total land size of 100,000 m2 with 10% allocated for solid foundations the remainder of the 90,000 m2 will be used to expand capacity with commercial polytunnels and allowing for future solar power generation plans.
Our Mission
“To become one of the leading producers of the highest quality medicinal cannabis in the European market, offering diverse strain selection through genetic research.”
Our experience and capabilities plus our strong relationships within the University of Cyprus and the pharmaceutical industry allow us to adapt quickly to evolving regulations whilst continuing to drive growth, shareholder value and meet the increasing demand in Europe.